thrombotic thrombocytopenic purpura
Information
- Disease name
- thrombotic thrombocytopenic purpura
- Disease ID
- DOID:10772
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01931644 | Completed | At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions | July 2013 | April 2024 | |
| NCT01554514 | Completed | Phase 2 | Low Dose Rituximab in Thrombotic Thrombocytopenic Purpura | August 2012 | February 14, 2020 |
| NCT00426686 | Completed | ADAMTS13 in Thrombotic Thrombocytopenic Purpura | November 2006 | April 2011 | |
| NCT04074187 | Completed | Phase 2/Phase 3 | A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) | October 21, 2019 | May 19, 2021 |
| NCT00713193 | Completed | Phase 3 | Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP) | November 2007 | September 20, 2017 |
| NCT03369314 | Completed | Observational Study of the Use of octaplasLG®. | March 2, 2018 | January 14, 2021 | |
| NCT02134171 | Completed | N/A | Early Predictive Factors of Cardiac and Cerebral Involvement in TMA | June 10, 2014 | July 30, 2017 |
| NCT00907751 | Completed | Phase 2 | Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura | May 2010 | August 2013 |
| NCT05568147 | Not yet recruiting | Phase 2/Phase 3 | Aspirin for Prophylaxis of TTP | October 1, 2022 | September 30, 2028 |
| NCT05785468 | Recruiting | A Retrospective, Observational Study on the Response to Caplacizumab Treatment in aTTP Patients: the Italian Experience (ROSCAPLI) | October 21, 2021 | March 30, 2023 | |
| NCT01257269 | Recruiting | Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome) | October 2006 | October 2030 | |
| NCT03187652 | Recruiting | A Prospective Study on the Long-Term Vascular Burden in Thrombotic Thrombocytopenic Purpura Patients | January 1, 2017 | January 1, 2026 | |
| NCT05389007 | Recruiting | .German TTP-Registry (Thrombotic Thrombocytopenic Purpura) | July 8, 2016 | ||
| NCT05468320 | Recruiting | Phase 3 | Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura | November 21, 2022 | December 13, 2024 |
| NCT00593229 | Terminated | International Registry and Biorepository for TMA(Thrombotic Microangiopathy) | January 2007 | ||
| NCT01938404 | Terminated | Octaplas Adult TTP Trial | June 6, 2017 | August 2, 2017 | |
| NCT00726544 | Terminated | Phase 2 | Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy | December 2008 | March 2011 |
| NCT00799773 | Terminated | Phase 3 | Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP) | April 2009 | February 2010 |
| NCT00953771 | Terminated | Phase 2 | Safety Study of Danazol With Plasma Exchange and Steroids for the Treatment of Thrombotic Thrombocytopenic Purpura (TTP) | October 2008 | November 19, 2015 |
| NCT04588194 | Unknown status | Phase 2 | Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia | November 1, 2020 | November 1, 2022 |
| NCT03237819 | Unknown status | Phase 3 | Magnesium Sulfate in Thrombotic Thrombocytopenic Purpura in Intensive Care | May 27, 2018 | December 1, 2021 |
| NCT03605511 | Unknown status | TTP and aHUS in Complicated Pregnancies | September 21, 2018 | March 14, 2020 | |
| NCT04981028 | Unknown status | The ConNeCT Study: Neurological Complications of TTP | June 25, 2020 | June 25, 2022 | |
| NCT00531089 | Unknown status | Phase 2 | Rituximab in Patients With Relapsed or Refractory TTP-HUS | December 2007 | January 2011 |
| NCT02626663 | Withdrawn | The Role of Microparticles as a Biomarker | July 2016 | December 2022 | |
| NCT00251277 | Withdrawn | Phase 1/Phase 2 | Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura | November 2005 | April 2009 |
- Disase is a (Disease Ontology)
- DOID:2452
- Cross Reference ID (Disease Ontology)
- GARD:9430
- Cross Reference ID (Disease Ontology)
- ICD10CM:M31.19
- Cross Reference ID (Disease Ontology)
- MESH:D011697
- Cross Reference ID (Disease Ontology)
- MIM:274150
- Cross Reference ID (Disease Ontology)
- NCI:C78797
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:360402008
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0034155
- Exact Synonym (Disease Ontology)
- Moschcowitz's syndrome
- OrphaNumber from OrphaNet (Orphanet)
- 54057